Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating pharmacokinetics, safety, and efficacy of two treatment modules in Chinese patients with moderate to severe Crohn's disease, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Two treatment modules (unnamed)

Snippet

Sponsor: AbbVie | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-05-13